Authors: Hakob Khachatryan, Gasparyan Gohar, Nahapetyan Zaruhi, Gohar Gevorgyan, Gagik Hakobyan.
Purpose: The aim of this study was to evaluate the long-term outcome of implant treatment in patients with previous tooth loss due to a history of moderate periodontitis and with type 2 diabetes mellitus.
Materials and methods: The study included 42 patients with partially edentulous, with a history of moderate periodontitis and with type 2 diabetes mellitus using 134 dental implants over the period from 2021 to 2023. ?t the baseline and at 3 month intervals bleeding on probing (BOP), probing depth (PD), marginal bone loss (MBL) were recorded. All patients prior implant surgery periodontal therapy were treated, which included the following: supragingival and subgingival scaling and root debridement were performed with an ultrasonic device, magnetic laser irradiation, local use of antibacterial agents.
Results: Implant surgery was performed 3 months after periodontal therapy, when PPD <4 mm and BOP <10%, with stable clinical index. ?fter 12-month in patients mean MBL 0.76±0.6 mm, after 5 years MBL was 1.34 ± 0.25 mm (P> 05), after 10 years MBL was 1.56 ± 0.28 mm (P> 05). Survival rate of implants 5 years after was 96.4% implants 10 years after was 93.6%.
Conclusions: This study confirmed that implant therapy can be successfully used in patients diagnosed with moderate periodontitis and with type 2 diabetes mellitus who have received individualization supportive periodontal therapy, regular periodontal maintenance and if their HbA1c level was <7.2% or less than 154 mg/dL.